Advertisement
Canada markets closed

  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • CAD/USD

    0.7282
    -0.0005 (-0.06%)
     

  • CRUDE OIL

    79.21
    +0.83 (+1.06%)
     

  • Bitcoin CAD

    85,350.06
    -1,335.40 (-1.54%)
     

  • CMC Crypto 200

    1,322.80
    +28.12 (+2.17%)
     

  • GOLD FUTURES

    2,317.10
    -7.10 (-0.31%)
     

  • RUSSELL 2000

    2,055.04
    -9.61 (-0.47%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • NASDAQ

    16,302.76
    -29.80 (-0.18%)
     

  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     

  • FTSE

    8,354.05
    +40.38 (+0.49%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • CAD/EUR

    0.6774
    +0.0003 (+0.04%)
     
MARKETS LIVE BLOG:

DOW POSTS 6TH DAY OF GAINS BUT NASDAQ SLIPS

Fed's Collins warns interest rates will likely stay higher for longer

Dermira, Inc. (DERM) Soars: Stock Adds 5.3% in Session

Zacks Equity Research
Updated

Dermira, Inc. DERM  was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $25.78–$27.52 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future. 

Dermira currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Dermira, Inc. Price and Consensus

Dermira, Inc. Price and Consensus | Dermira, Inc. Quote

ADVERTISEMENT

A better ranked stock in the Medical - Drugs industry is MEI Pharma, Inc..MEIP which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is DERM going up? Or down? Predict to see what others think: Up or Down

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MEI Pharma, Inc. (MEIP) : Free Stock Analysis Report
 
Dermira, Inc. (DERM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research